NCT03760952View on ClinicalTrials.gov

Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling

CompletedOBSERVATIONAL
Enrollment

242

Participants

Timeline

Start Date

February 26, 2019

Primary Completion Date

November 15, 2022

Study Completion Date

November 15, 2022

Conditions
Refractory CancerRecurrent CancerAdult Solid TumorNeoplasms
Trial Locations (4)

10032

Columbia University Medical Center, New York

15232

University of Pittsburgh Medical Center, Pittsburgh

60637

University of Chicago, Chicago

77030

Oncology Consultants, Houston

All Listed Sponsors
lead

Immatics US, Inc.

INDUSTRY

NCT03760952 - Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling | Biotech Hunter | Biotech Hunter